CONSIDERATIONS IN THE TREATMENT OF DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA
The ongoing diabetes epidemic remains a pressing public health issue in the United States and abroad. Diabetes and prediabetes can result in a multitude of systemic macro- and microvascular pathologies affecting major organ systems, with potentially devastating consequences for patients and their families. One of the most troubling complications is diabetic retinopathy, which is a major cause of blindness in working-age adults in the United States.
Now available is “Achieving Improved Outcomes Through Partnerships Between Optometrists and Retina Specialists,” a new consensus paper authored by leading eye specialists that reviews key considerations in the identification and treatment of diabetic retinopathy and diabetic macular edema. The paper includes a commentary co-authored by Ray Roth, DO, MBA, a former medical director at Geisinger Health Plan and a longtime member of the payer community. The commentary discusses opportunities to better integrate payer efforts to promote quality eye care in patients with diabetes in alignment with healthcare professionals on the front lines. We are sure that you will find this publication to be an informative and interesting look at unified strategies to promote and maintain eye health in this vulnerable patient population.